News Archives
2008 News
VGX Pharmaceuticals sign multi-year production agreement with the Cystic Fibrosis Gene Therapy
Consortium
12.05.08
VGX
Pharmaceuticals announced that the company has signed a multi-year
agreement to provide plasmid DNA to support the ongoing toxicology and
clinical trials of the United Kingdom Cystic Fibrosis Gene Therapy
Consortium. Under the terms of the agreement, VGX will provide
multiple batches of a CFTR product to support clinical studies planed to
run to 2010.